The FDA granted fast track designation to SAR446597, an intravitreal gene therapy for the treatment of geographic atrophy due to age-related macular degeneration, according to a press release from ...

About 1,300 Whole Foods employees have been upskilled in an artisan craft from fishmongering to cake decorating, offering ...

The Black & Wood Pellets Industry Analysis in Europe reveals a rapidly evolving market poised for exceptional growth. Valued ...

The US Food and Drug Administration (FDA) recently granted fast track designation to Sanofi’s SAR446597 for the treatment of geographic atrophy (GA). 1 ...

US FDA grants fast track designation to Sanofi’s SAR446597 to treat geographic atrophy due to age-related macular degeneration: Paris Thursday, July 17, 2025, 10:00 Hrs [IST] Th ...

Arlington, Va. — The House Armed Services Committee (HASC) filed the bill for the 2026 National Defense Authorization Act, ...

Discover how CrazyBulk’s natural legal steroids are transforming muscle building supplements for bodybuilding women seeking ...

SNY's SAR446597, a one-time intravitreal gene therapy, secures FDA fast track tag for geographic atrophy due to age-related ...

Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a clinical ...

Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time ...

Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for a one-time intravitreal gene therapy designed to inhibit ...

Embracing technology in CTE helps prepare a future-ready workforce adept at leveraging technology for problem-solving and ...